drugset / Trial / NCT00352963

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

NCT00352963

Phase 3 Completed 480 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

This study will evaluate the immunogenicity of the co-administration of different combinations of DTPa, IPV, hepatitis B, Hib and Men C vaccines during the first year of life.

Timeline

Start
2003-09-30
Primary completion
Completion
2004-07-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject IH Vaccine
Subject Meningitec Vaccine
Subject Menitorix Vaccine
Subject NVC Vaccine